← Browse by Condition
Medical Condition

sepsis

Total Trials
27
Recruiting Now
27
Trial Phases
Phase 4, Phase 3, Phase 1
NCT07040202
Recruiting

Immune Responses to Dengue and Sepsis

Enrollment
240 pts
Location
Cambodia
Sponsor
Institut Pasteur du Cambodge
View Trial →
NCT02979951
Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

Enrollment
1,000 pts
Location
Austria, Germany, Gr...
Sponsor
Infectopharm Arzneimittel GmbH
View Trial →
NCT06694181
Recruiting

Safe and Explainable AI

Enrollment
300,000 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn...
View Trial →
NCT07230067
Recruiting

Sepsis-associated Thrombocytopenia and Platelet Transfusion (STAPT)

Enrollment
1,500 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
View Trial →
NCT04130789
Recruiting

Personalized Swiss Sepsis Study

Enrollment
17,500 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw...
View Trial →
NCT06368388
Recruiting

Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force

Enrollment
50 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
View Trial →
NCT07448805
Recruiting

Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

Enrollment
100 pts
Location
Slovenia
Sponsor
University Medical Centre Mari...
View Trial →
NCT07172451 Phase 4
Recruiting

Gelaspan vs Crystalloid Therapy in Sepsis

Enrollment
318 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →
NCT05770622 Phase 4
Recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)

Enrollment
40 pts
Location
Australia
Sponsor
Murdoch Childrens Research Ins...
View Trial →
NCT05565222 Phase 3
Recruiting

Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit

Enrollment
600 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT05453695 Phase 1
Recruiting

Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)

Enrollment
36 pts
Location
Canada
Sponsor
McMaster University
View Trial →
NCT05634057
Recruiting

Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

Enrollment
782 pts
Location
China
Sponsor
Chen Ying
View Trial →
NCT07287332
Recruiting

BLOOM: Pragmatic Feasibility Trial

Enrollment
300 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07060560
Recruiting

Presepsin Diagnostic Performance in Severe Burn Sepsis

Enrollment
138 pts
Location
South Korea
Sponsor
Dohern Kym
View Trial →
NCT02707497 Phase 2, Phase 3
Recruiting

The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia

Enrollment
200 pts
Location
China
Sponsor
Ruilan Wang
View Trial →
NCT06178822
Recruiting

Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

Enrollment
3,300 pts
Location
Netherlands
Sponsor
Amsterdam University Medical C...
View Trial →
NCT07084129 Phase 1
Recruiting

Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

Enrollment
20 pts
Location
United States
Sponsor
Children's Hospital of Philade...
View Trial →
NCT06476171
Recruiting

Validation of Hematological Indices

Enrollment
200 pts
Location
Russia
Sponsor
Petrovsky National Research Ce...
View Trial →
NCT06624436 Phase 4
Recruiting

Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia

Enrollment
52 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen...
View Trial →
NCT05758246 Phase 2
Recruiting

Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

Enrollment
220 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT06116656
Recruiting

Changes in Host Gene Expression to Differentiate Between Systemic Inflammation and Infection After Major Surgery

Enrollment
150 pts
Location
Netherlands
Sponsor
St. Antonius Hospital
View Trial →
NCT05623722
Recruiting

Erector Spinae Plane Block Improves Organ Dysfunction in Septic Patients With Acute Gastrointestinal Injury

Enrollment
116 pts
Location
China
Sponsor
Jing Cai, MD
View Trial →
NCT05304221
Recruiting

A Prospective Cluster-Randomized, Controlled Crossover Trial to Validate an Electronic "Resistance Calculator"

Enrollment
1,500 pts
Location
Israel
Sponsor
Dror MarChaim, MD
View Trial →
NCT05634733
Recruiting

Change in MAPSE During Treatment of Sepsis

Enrollment
50 pts
Location
United States
Sponsor
University of Maryland, Baltim...
View Trial →
NCT06219135
Recruiting

Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis

Enrollment
1,372 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT06184659 Phase 4
Recruiting

Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis

Enrollment
5,800 pts
Location
Denmark
Sponsor
Scandinavian Critical Care Tri...
View Trial →
NCT06824350
Recruiting

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Enrollment
45,450 pts
Location
United States, Kenya
Sponsor
University of California, Berk...
View Trial →